drugset / Trial / NCT04899180

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

NCT04899180 ↗

Phase 0 Completed 4 enrolled Mayo Clinic
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine the prevalence of transthyretin cardiac amyloidosis (TTR-CA) among patients with moderate and severe aortic stenosis in Southeast Minnesota using 99mTc-PYP single-photon positive emission computed tomography with computed tomography (SPECT/CT).

Timeline

Start
2023-07-14
Primary completion
2024-01-05
Completion
2024-01-05

Drugs

EvaluationDrugModalityDoseRoute
Subject 99mTc-PYP Diagnostic / imaging agent — —